Video Experimental Relacionado
Updated: Jun 21, 2026
08:16
Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus
Published on: June 17, 2015
La amiloide β instiga el deterioro de la señalización neurotrófica cardíaca, impulsando la enfermedad cardíaca
Andrea Elia1, Rebecca Parodi-Rullan1,2, Rafael Vazquez-Torres1
1Alzheimer's Center at Temple (ACT), Department of Neural Sciences, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, USA.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|February 10, 2026
Resumen
La patología de la enfermedad de Alzheimer (EA), incluida la deposición de beta-amiloide (Aβ), afecta directamente la función cardíaca al interrumpir la señalización neurotrófica y causar denervación cardíaca. Este estudio revela un nuevo vínculo entre la enfermedad de Alzheimer y la degeneración cardíaca.
Área de la Ciencia:
- Ciencias Cardiovasculares Ciencias Cardiovasculares
- La neurociencia es la neurociencia.
- Patología Patología Patología.
Sus antecedentes:
- Los factores de riesgo cardiovascular están relacionados con el riesgo de enfermedad de Alzheimer (EA).
- El impacto directo de la patología de la EA en la función cardíaca y la inervación no se comprende bien.
- La amiloidosis y los trastornos de la señalización neurológica en la EA pueden conducir a déficits del sistema nervioso periférico y problemas cardíacos.
Objetivo del estudio:
- Investigar los efectos de la patología de la EA en la fisiología cardíaca, la deposición de amiloide, los factores neurotróficos y las fibras neuronales.
- Para dilucidar los mecanismos por los cuales el beta-amiloide (Aβ) interrumpe la señalización y la función neurotrófica cardíaca.
Principales métodos:
- Se estudiaron corazones de ratones Tg2576-AD, cardiomiocitos humanos (en cultivo) y tejido ventricular izquierdo (LV) humano post-mortem.
- Se evaluó la fibrosis miocárdica, la deposición de Aβ, la expresión del factor neurotrófico (BDNF) y la integridad de la fibra neuronal cardíaca.
- Investigó el impacto de los oligómeros Aβ en la expresión de BDNF y la señalización de TrkB/CREB en los cardiomiocitos.
Principales resultados:
- Los ratones Tg2576-AD mostraron un aumento de la fibrosis miocárdica, la deposición de Aβ y las deficiencias neurotróficas del cerebro / corazón, lo que condujo a la denervación y la disfunción cardíaca.
- Los oligómeros Aβ redujeron la expresión de BDNF en los cardiomiocitos humanos al interrumpir la señalización TrkB/CREB.
- Los tejidos humanos LV AD confirmaron los hallazgos observados en modelos animales y celulares.
Conclusiones:
- La patología de la enfermedad de Alzheimer afecta directamente la fisiología cardíaca a través de la deposición de amiloide y la pérdida de factor neurotrófico.
- La patología Aβ interrumpe la señalización neurotrófica cardíaca y la inervación neuronal, contribuyendo a la degeneración del corazón.
- Este estudio identifica un posible vínculo mecánico entre la EA y la disfunción cardíaca.
Videos de Conceptos Relacionados
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:21Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...